National Institutes of Health: Toxemia trials

The registry lists 12 Toxemia studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 2Phase 3 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)RecruitingNCT05189925Phase 1
• Statins for Acutely Injured Lungs From SepsisTerminatedNCT00979121Phase 3Results posted
• Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in SepsisCompletedNCT00608322Phase 3Results posted
• Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of SepsisWithdrawnNCT04698382
• Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
• Clinical Trial of the Optimal Endpoint of Early Sepsis ResuscitationCompletedNCT00372502Not applicable
• Protocol-driven Hemodynamic Support for Patients With Septic ShockStatus unknownNCT00335907Not applicable
• Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 2
• Regulation of Placental Vascular Reactivity in Pregnancy-induced HypertensionCompletedNCT00005208
• Renin and Prorenin in PregnancyCompletedNCT00005207
• Oral Calcium in Pregnant Women With HypertensionCompletedNCT00000543Phase 2
• Calcium for Pre-Eclampsia Prevention (CPEP)CompletedNCT00000534Phase 3